Market›Health Care›Biotechnology›Biotechnology
GENFLOW BIOSCIENCES

GENFF

$0.04Jun 15, 2023 – Apr 27, 2026
Health CareBiotechnology$22M
MVM
+$0.0M

Every news event mapped to its market reaction — 25 events, 35 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2026-04-20+114.8%executiveProactiveGenflow Biosciences CEO on Acuitas collaboration: non-dilutive growth catalyst
2026-04-20+114.8%M&AProactiveGenflow Biosciences strikes LNP delivery deal with mRNA vaccine technology pioneer
2026-04-20+114.8%newsACCESS NewswireGenflow Biosciences PLC Announces Strategic Technology Collaboration
2025-10-09+95.3%newsShare TalkGenflow Biosciences (LON: GENF) Shares Jump 100% After Alternative Share Placement - Share Talk
2025-10-09+95.3%M&AProactive InvestorsGenflow shares surge 88% after new funding deal deemed less dilutive - Proactive Investors
2026-04-19+87.4%newsStock TitanGenflow gets fully funded access to Acuitas mRNA delivery tech - Stock Titan
2025-09-19+85.4%newsShare TalkGenflow Biosciences (LON: GENF) Files Patent Examination Request in China for SIRT6 Variants in NASH - Share Talk
2025-02-20-31.6%newsShare TalkGenflow Biosciences (LON:GENF) Advancements in SIRT6 Variant Patent Application - Share Talk
2026-01-08+30.3%newsShare TalkGenflow Biosciences PLC (LON: GENF) A Review of an Exciting 2025 - Share Talk
2025-10-22+30.3%legalSeeking AlphaGenflow Biosciences announces second European patent application
2025-12-11-24.2%newsShare TalkGenflow Biosciences Plc (LON: GENF) to pitch longevity gene therapy at JPM 2026 - Share Talk
2026-03-31-3.7%newsACCESS NewswireGenflow Biosciences PLC Announces Total Voting Rights
2026-04-08-3.1%newsProactiveGenflow reports sustained safety and efficacy three months after gene therapy dosing in dog trial
2026-03-30-2.6%newsStock TitanGenflow sets 535.7M-share count investors must use for FCA notices - Stock Titan
2026-04-13-2.2%newsProactiveArecor Therapeutics, Great Southern Copper, Powerhouse Energy, Genflow Biosciences, Gelion
2026-04-13-2.2%newsProactiveGenflow Biosciences expands SIRT6 patent protection into muscular diseases
2026-04-13-2.2%newsACCESS NewswireGenflow Biosciences PLC Announces International Patent Publication
2026-03-05+1.9%newsACCESS NewswireGenflow Biosciences PLC Announces Issue of Equity & PDMR Notifications
2025-03-26+1.5%newsStock TitanMajor Investment Fuels Genflow's Revolutionary Anti-Aging Gene Therapy Dog Trial - Stock Titan
2025-12-16+1.4%newsShare TalkGenflow Biosciences Plc (LON: GENF) Completion of Dosing Phase of Canine Gene Therapy - Share Talk
2025-10-10+1.2%newsShare TalkGenflow Biosciences Shares Jump 25% on Positive Dog Aging Gene Therapy Results - Share Talk
2026-04-12-1.0%newsStock TitanPatent publication widens Genflow's SIRT6 reach into muscle disease - Stock Titan
2026-04-11-1.0%executiveProactiveGenflow CEO on promising SLAB trial data - ICYMI
2023-09-28-0.3%earningsSeeking AlphaGenflow Biosciences GAAP EPS of -0.21p
2024-10-21+0.2%legalStock TitanGenflow Secures Non-Dilutive Financial Support - Stock Titan
tickerdossier.comtickerdossier.substack.com